Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899425 | PMC |
| http://dx.doi.org/10.1590/1516-4446-2017-2372 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Does Physicians' Clinical Competence, Communication Ability, or Cultural Background Influence Potentially Inappropriate Prescribing of Benzodiazepines and Z-Drugs Among Older Adults With Insomnia?
Pharmacoepidemiol Drug Saf
December 2024
Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Article Synopsis
- The study aims to examine how factors like physician age, sex, clinical and communication skills, and cultural background influence the prescribing of benzodiazepines (BDZ) to older adults with insomnia.
- A cohort of international medical graduates (IMGs) treated Medicare patients from 2014-2015, and the analysis showed that U.S.-born IMGs were more likely to prescribe BDZs, particularly those from the U.K. being the least likely.
- Findings indicate that older physicians tend to prescribe BDZs more often, suggesting that addressing these cultural and age-related factors could help reduce inappropriate medication use.
Effects of Approved Pharmacological Interventions for Insomnia on Mood Disorders: A Systematic Review.
Clin Neuropsychiatry
October 2024
Department of Surgical, Medical and Molecular Pathology, Critical and Care Medicine, University of Pisa, Pisa, Italy, Department of Neuroscience, Azienda Ospedaliera Universitaria Pisana (AUOP), Pisa, Italy.
Objective: Insomnia can be a contributing factor, a comorbid disorder, or a transdiagnostic element to several mental disorders, including mood disorders (MDs). A recent meta-analysis has already shown the effectiveness of cognitive behavioral treatment (CBT) for insomnia that is comorbid with MDs. This work aimed to systematically review data on pharmacological insomnia treatment in the context of MDS.
View Article and Find Full Text PDFBrazil Tightens the Reins on Z-Drugs: New Regulations for Zolpidem and Eszopiclone.
Braz J Psychiatry
June 2024
Departamento de Psiquiatria, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Assessing the prevalence of Beers medication utilization in the Medicare Part D population in 2020.
J Am Geriatr Soc
September 2024
University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA.
Background: Medication utilization has been increasing in the U.S. year-over-year for several decades.
View Article and Find Full Text PDFTrends in Pregabalin Use and Prescribing Patterns in the Adult Population: A 10-Year Pharmacoepidemiologic Study.
CNS Drugs
February 2024
Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.
Background And Objective: Pregabalin is steadily gaining popularity worldwide, with epidemiological studies indicating an increase in labeled, off-labeled, and recreational uses. In Israel, pregabalin prescriptions are not regulated by the controlled substances legislations, prompting a need to examine its usage trends for potential policy adjustments. The objective of this study was to assess trends in pregabalin prescribing during a 10-year period, to characterize demographic and clinical characteristics of individuals prescribed pregabalin, and to identify risk factors associated with high-intensity pregabalin use.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!